Differential activation of wild-type estrogen receptor α and C-terminal deletion mutants by estrogens, antiestrogens and xenoestrogens in breast cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 103, Issue 1, 2007, Pages 1-9

  Wu, Fei ^a   Safe, Stephen ^a,b,c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

ER ; SERMs; Transactivation; Xenoestrogens

Indexed keywords

1,1,1 TRICHLORO 2,2 BIS(4 HYDROXYPHENYL)ETHANE; 2',3',4',5' TETRACHLORO 4 BIPHENYLOL; 4 HYDROTAMOXIFEN; 4 NONYLPHENOL; 4 TERT OCTYLPHENOL; 4,4' ISOPROPYLIDENEDIPHENOL; AMINO ACID; ANTIESTROGEN; CHLORDECONE; DIETHYLSTILBESTROL; ENDOSULFAN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; LUCIFERASE; PHENOL DERIVATIVE; PHYTOESTROGEN; RESVERATROL; TAMOXIFEN DERIVATIVE; TRICHLOROETHANE; XENOESTROGEN;

ARTICLE; BREAST CANCER; CANCER CELL; CARBOXY TERMINAL SEQUENCE; CELL ASSAY; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DELETION MUTANT; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; ESTROGEN ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; GENE CONSTRUCT; GENE DELETION; GENETIC TRANSFECTION; HORMONAL REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MUTANT; OBSERVATION; TRANSACTIVATION; WILD TYPE;

BREAST NEOPLASMS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR MODULATORS; ESTROGENS; HUMANS; MUTATION; TANDEM REPEAT SEQUENCES; TRANS-ACTIVATION (GENETICS); TRANSFECTION;

EID: 33751418943     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.07.007     Document Type: Article

References (37)

1. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., and Evans R.M. The nuclear receptor superfamily: the second decade. Cell 83 (1995) 835-839
2. Altucci L., and Gronemeyer H. Nuclear receptors in cell life and death. Trends Endocrinol. Metab. 12 (2001) 460-468
3. Nilsson S., and Gustafsson J.A. Biological role of estrogen and estrogen receptors. Crit. Rev. Biochem. Mol. Biol. 37 (2002) 1-28
4. Olefsky J.M. Nuclear receptor minireview series. J. Biol. Chem. 276 (2001) 36863-36864
5. Hall J.M., Couse J.F., and Korach K.S. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J. Biol. Chem. 276 (2001) 36869-36872
6. Chambon P. The nuclear receptor superfamily: a personal retrospect on the first two decades. Mol. Endocrinol. 19 (2005) 1418-1428
7. Evans R.M. The nuclear receptor superfamily: a rosetta stone for physiology. Mol. Endocrinol. 19 (2005) 1429-1438
8. Safe S. Clinical correlates of environmental endocrine disruptors. Trends Endocrinol. Metab. 16 (2005) 139-144
9. Sharpe R.M., and Skakkebaek N.F. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract. Lancet 341 (1993) 1392-1395
10. Skakkebaek N.E., Rajpert-De M.E., and Main K.M. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum. Reprod. 16 (2001) 972-978
11. Katzenellenbogen J.A., O'Malley B.W., and Katzenellenbogen B.S. Tripartite steroid hormone receptor pharmacology-interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol. Endocrinol. 10 (1996) 119-131
12. Smith C.L., and O'Malley B.W. Coregulator function: a key to understanding tissue specificity of selected receptor modulators. Endocr. Rev. 25 (2004) 45-71
13. Tzukerman M.T., Esty A., Santiso-Mere D., Danielian P., Parker M.G., Stein R.G., Pike J.W., and McDonnell D.P. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8 (1994) 21-30
14. McDonnell D.P., Clemm D.L., Hermann T., Goldman M.E., and Pike J.W. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol. Endocrinol. 9 (1995) 659-669
15. Jordan V.C., Schafer J.M., Levenson A.S., Liu H., Pease K.M., Simons L.A., and Zapf J.W. Molecular classification of estrogens. Cancer Res. 61 (2001) 6619-6623
16. An J., Tzagarakis-Foster C., Scharschmidt T.C., Lomri N., and Leitman D.C. Estrogen receptor β-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J. Biol. Chem. 276 (2001) 17808-17814
17. Barkhem T., Carlsson B., Nilsson Y., Enmark E., Gustafsson J., and Nilsson S. Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists. Mol. Pharmacol. 54 (1998) 105-112
18. Mueller S.O., Simon S., Chae K., Metzler M., and Korach K.S. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor α (ERα) and ERβ in human cells. Toxicol. Sci. 80 (2004) 14-25
19. Hall J.M., McDonnell D.P., and Korach K.S. Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements. Mol. Endocrinol. 16 (2002) 469-486
20. Nishikawa J., Saito K., Goto J., Dakeyama F., Matsuo M., and Nishihara T. New screening methods for chemicals with hormonal activities using interaction of nuclear hormone receptor with coactivator. Toxicol. Appl. Pharmacol. 154 (1999) 76-83
21. Sheeler C.Q., Dudley M.W., and Khan S.A. Environmental estrogens induce transcriptionally active estrogen receptor dimers in yeast: activity potentiated by the coactivator RIP140. Environ. Health Perspect. 108 (2000) 97-103
22. Routledge E.J., White R., Parker M.G., and Sumpter J.P. Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) α and ERβ. J. Biol. Chem. 275 (2000) 35986-35993
23. Matthews J.B., Fertuck K.C., Celius T., Huang Y.W., Fong C.J., and Zacharewski T.R. Ability of structurally diverse natural products and synthetic chemicals to induce gene expression mediated by estrogen receptors from various species. J. Steroid Biochem. Mol. Biol. 82 (2002) 181-194
24. Hutzinger O., Safe S., and Zitko V. Preparation, gas chromatography behavior, and spectroscopic properties of hydroxylated chlorobiphenyls. J. Assoc. Off. Anal. Chem. 57 (1974) 1061-1067
25. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Häggblad J., Nilsson S., and Gustafsson J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138 (1997) 863-870
26. Schwartz J.A., Zhong L., Deighton-Collins S., Zhao C., and Skafar D.F. Mutations targeted to a predicted helix in the extreme carboxyl-terminal region of the human estrogen receptor-alpha alter its response to estradiol and 4-hydroxytamoxifen. J. Biol. Chem. 277 (2002) 13202-13209
27. Gould J.C., Leonard L.S., Maness S.C., Wagner B.L., Connor K., Zacharewski T., Safe S., McDonnell D.P., and Gaido K.W. Bisphenol A interacts with the estrogen receptor α in a distinct manner from estradiol. Mol. Cell. Endocrinol. 142 (1998) 203-214
28. Yoon K., Pallaroni L., Ramamoorthy K., Gaido K., and Safe S. Ligand structure-dependent differences in activation of estrogen receptor α in human HepG2 liver and U2 osteogenic cancer cell lines. Mol. Cell. Endocrinol. 162 (2000) 211-220
29. Yoon K., Pallaroni L., Stoner M., Gaido K., and Safe S. Differential activation of wild-type and variant forms of estrogen receptor α by synthetic and natural estrogenic compounds using a promoter containing three tandem estrogen-responsive elements. J. Steroid Biochem. Mol. Biol. 78 (2001) 25-32
30. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S., Van der Saag P.T., Van der Burg B., and Gustafsson J.-A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139 (1998) 4252-4263
31. Wijayaratne A.L., and McDonnell D.P. The human estrogen receptor-α is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators. J. Biol. Chem. 276 (2001) 35684-35692
32. McDougal A., Wormke M., Calvin J., and Safe S. Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective Ah receptor modulator. Cancer Res. 61 (2001) 3901-3907
33. Laios I., Journe F., Laurent G., Nonclercq D., Toillon R.A., Seo H.S., and Leclercq G. Mechanisms governing the accumulation of estrogen receptor α in MCF-7 breast cancer cells treated with hydroxytamoxifen and related antiestrogens. J. Steroid Biochem. Mol. Biol. 87 (2003) 207-221
34. Fan M., Bigsby R.M., and Nephew K.P. The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-α and essential for the antiproliferative activity of ICI 182, 780 in ERα-positive breast cancer cells. Mol. Endocrinol. 17 (2003) 356-365
35. Kim K., Thu N., Saville B., and Safe S. Domains of estrogen receptor α (ERα) required for ERα/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells. Mol. Endocrinol. 17 (2003) 804-817
36. Montano M.M., Müller V., Trobaugh A., and Katzenellenbogen B.S. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists. Mol. Endocrinol. 9 (1995) 814-825
37. Nichols M., Rientjes J.M., and Stewart A.F. Different positioning of the ligand-binding domain helix 12 and the F domain of the estrogen receptor accounts for functional differences between agonists and antagonists. EMBO J. 17 (1998) 765-773